NCT01591746View on ClinicalTrials.gov

Botulinum Toxin A (Botox) in Tissue Expander Breast Reconstruction

PHASE3CompletedINTERVENTIONAL

Enrollment

131

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

July 18, 2017

Study Completion Date

July 18, 2017

Conditions

Breast CancerPain, PostoperativeBRCA1 MutationBRCA2 MutationBreast DiseasesNeoplasms

Interventions

DRUG

Botulinum Toxin Type A

DRUG

Placebo

5 mL 0.9% NaCl solution to mimic Botulinum Toxin Type A

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Allergan

INDUSTRY

lead

Mayo Clinic

OTHER